Ligand validation:6P22

PLM: PALMITIC ACID

PLM is a Ligand Of Interest in 6P22 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6P22_PLM_C_601	17%	55%	0.249	0.828	0.58	1.13	-	1	0	0	100%	1
6P20_PLM_B_602	29%	54%	0.186	0.843	0.58	1.18	-	1	1	0	100%	1
4JIV_PLM_A_602	25%	59%	0.219	0.855	0.61	0.97	-	-	2	0	100%	1
5GIX_PLM_A_603	100%	68%	0.048	0.99	0.48	0.73	-	-	3	0	100%	1
4TKJ_PLM_A_201	99%	67%	0.056	0.987	0.64	0.62	-	-	0	0	100%	1
5B28_PLM_A_201	99%	74%	0.059	0.986	0.43	0.59	-	-	0	0	100%	1
4BVM_PLM_A_1132	98%	53%	0.062	0.988	0.62	1.17	-	2	1	0	100%	0.46
6S2S_PLM_A_203	98%	44%	0.069	0.988	1.32	0.86	4	-	1	0	100%	0.5

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.